# An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families

> **NCT04723693** · — · COMPLETED · sponsor: **Haemnet** · enrollment: 30 (actual)

## Conditions studied

- Hemophilia A With Inhibitor

## Interventions

- **OTHER:** Qualitative Interview

## Key facts

- **NCT ID:** NCT04723693
- **Lead sponsor:** Haemnet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-28
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04723693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04723693, "An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04723693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*